Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel Midgley

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 18, 2011
KRAS mutation is associated with lung metastasis in patients with curatively resected colorectal cancerJeanne Tie, Lara Lipton, Jayesh Desai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 5, 2014
Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysisDan Rosmarin, Claire Palles, David Church, et al.
Nature Genetics|October 26, 2010
Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33Richard S Houlston, Jeremy Cheadle, Sara E Dobbins, et al.
Nature Genetics|May 29, 2012
Common variation near CDKN1A, POLD3 and SHROOM2 influences colorectal cancer riskMalcolm G Dunlop, Sara E Dobbins, Susan Mary Farrington, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 18, 2011
KRAS mutation is associated with lung metastasis in patients with curatively resected colorectal cancerJeanne Tie, Lara Lipton, Jayesh Desai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 5, 2014
Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysisDan Rosmarin, Claire Palles, David Church, et al.
Nature Genetics|October 26, 2010
Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33Richard S Houlston, Jeremy Cheadle, Sara E Dobbins, et al.
Nature Genetics|May 29, 2012
Common variation near CDKN1A, POLD3 and SHROOM2 influences colorectal cancer riskMalcolm G Dunlop, Sara E Dobbins, Susan Mary Farrington, et al.
Pageof 3